guardionhealth.com - רווח לפני ריבית, מסים ופחת GHSI

Steady demand for retinal nutraceuticals creates a loyal customer base, while the estimated EBITDA shown on this GURU.Markets chart indicates that the value represents the current operating profit. However, intense competition from pharma behemoths and the risks of efficacy audits pressure the business, which offsets this by implementing ESG standards and eco-friendly raw material packaging for Guardion Health Science (GHSI).

This indicator determines the net cash flow from operating activities, excluding the impact of depreciation and taxes to assess the business's actual ability to generate cash. By analyzing the actual operating profit on GURU.Markets, an investor can see the commercialization efficiency of Guardion Health Science (GHSI) ophthalmological supplements and diagnostics, which provides insight into the market confidence of physicians in their evidence base.